Want to see MNPR full AI Analyst Report?
Monopar Therapeutics Inc (MNPR) Drug Pipeline
| Drug Name | Condition | Stage | Status | Study Name | Trial Start Date | Article |
|---|---|---|---|---|---|---|
| Mnpr-101-Pcta-177Lu | Ovarian Cancer, Bladder Cancer, Urothelial Carcinoma, Colorectal Cancer, Pancreatic Cancer, Lung Cancer, Gastric Cancer, Triple-Negative Breast Cancer, Solid Tumor, Adult | Phase I | Recruiting | Dose-Escalation of MNPR-101-PCTA-177Lu in Solid Tumors | Sep 18, 2024 | ― |
| Mnpr-101-Dfo*-89Zr, Pet/Ct Diagnostic Imaging | Ovarian Cancer, Bladder Cancer, Urothelial Carcinoma, Colorectal Cancer, Pancreatic Cancer, Lung Cancer, Gastric Cancer, Triple-Negative Breast Cancer, Solid Tumor, Adult | Phase I | Recruiting | Diagnostic Efficacy and Dosimetry of MNPR-101-DFO*-89Zr in Patients With Solid Tumors | Mar 22, 2024 | ― |
| Drug Name | Stage | Condition | Status | Study Name | Trial Start Date | Article |
|---|---|---|---|---|---|---|
| Mnpr-101-Pcta-177Lu | Phase I | Ovarian Cancer, Bladder Cancer, Urothelial Carcinoma, Colorectal Cancer, Pancreatic Cancer, Lung Cancer, Gastric Cancer, Triple-Negative Breast Cancer, Solid Tumor, Adult | Recruiting | Dose-Escalation of MNPR-101-PCTA-177Lu in Solid Tumors | Sep 18, 2024 | ― |
| Mnpr-101-Dfo*-89Zr, Pet/Ct Diagnostic Imaging | Phase I | Ovarian Cancer, Bladder Cancer, Urothelial Carcinoma, Colorectal Cancer, Pancreatic Cancer, Lung Cancer, Gastric Cancer, Triple-Negative Breast Cancer, Solid Tumor, Adult | Recruiting | Diagnostic Efficacy and Dosimetry of MNPR-101-DFO*-89Zr in Patients With Solid Tumors | Mar 22, 2024 | ― |
FAQ
What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases: a. Preclinical testing b. Phase 1 – Safety and dosage c. Phase 2 – Effectiveness and side effects d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does Monopar Therapeutics Inc (MNPR) have in its pipeline
Monopar Therapeutics Inc MNPR is currently developing the following drugs: Mnpr-101-Pcta-177Lu, Mnpr-101-Dfo*-89Zr, Pet/Ct Diagnostic Imaging. These drug candidates are in various stages of clinical development as the company works toward FDA approval.